Loading organizations...
Loading organizations...
Town Hall Ventures is a healthcare-focused venture capital firm investing in companies transforming care for underserved populations. It partners with founders developing technology and service solutions to improve poorly served healthcare segments. Their collaborative approach scales breakthrough companies, addressing critical patient needs in school-based mental health and care for frail seniors.
Established in 2018, Town Hall Ventures was founded by Andy Slavitt and David Whelan. Slavitt, a former Optum Group EVP and head of CMS, combined his public sector expertise with Whelan, a seasoned investor. Their insight identified an opportunity for innovative solutions addressing systemic healthcare inequities.
The firm’s portfolio companies serve Americans in communities often overlooked by traditional healthcare, including rural areas and vulnerable populations. Town Hall Ventures' vision cultivates category-defining businesses delivering substantial financial returns and meaningful societal impact. They support entrepreneurs building lasting enterprises to enhance equitable access and quality of care.
Key people at Town Hall Ventures.
Town Hall Ventures is a healthcare-focused venture capital firm that combines financial investment with deep operational expertise to support companies transforming care delivery for underserved American populations[1][2]. Founded in 2018, the firm manages approximately $919 million in assets under management across three funds and has deployed capital into 42 companies, with 8 of the first 16 investments reaching valuations exceeding $1 billion[1][2].
The firm's mission centers on achieving top-quartile financial returns while solving entrenched healthcare access problems in communities historically neglected by the U.S. healthcare system[2]. Rather than pursuing purely commercial opportunities, Town Hall targets healthcare technology and services businesses that demonstrate both scalability ambitions and genuine commitment to serving low-income and underserved populations[1][3]. The firm invests across early to growth stages, with initial checks ranging from $3 million to $30 million, and provides ongoing capital throughout a company's lifecycle[3].
Town Hall Ventures emerged from the unique vantage point of its co-founders, who collectively possess rare insight into both public and private healthcare systems[5]. Andy Slavitt, the firm's Managing Partner and co-founder, served as acting administrator of the Centers for Medicare and Medicaid Services (CMS) under the Obama administration and previously held the position of Executive Vice President at Optum Group[1][2]. David Whelan, the other co-founder, brings extensive experience as a long-time investor and company-builder[2]. Trevor Price rounds out the founding team[1].
This combination of government policy expertise, private sector operational experience, and investment acumen directly shaped the firm's founding thesis. Rather than starting as a traditional venture fund, Town Hall was conceived as a platform to bridge the gap between healthcare innovation and the populations most in need of better care delivery models. The firm's track record—with eight of its first sixteen investments achieving unicorn status—validates this approach and demonstrates that mission-driven healthcare investing can generate exceptional financial returns[2].
Town Hall's competitive advantage stems from its founders' deep relationships across the healthcare ecosystem. The firm leverages connections with C-suite executives at major health systems, national payers, and policymakers to accelerate customer acquisition for portfolio companies[3]. This network translates into tangible business value: portfolio companies gain credibility and sales velocity that would take years to build independently.
Unlike traditional venture firms that provide capital and board seats, Town Hall functions as an active operating partner[1]. The firm helps portfolio companies refine go-to-market strategies, build world-class management teams, and navigate complex healthcare policy and payment landscapes[3]. This support model reflects the founders' company-building experience and acknowledges that healthcare ventures face unique regulatory, reimbursement, and stakeholder challenges that require more than capital.
Town Hall prioritizes team quality, business model viability, and mission alignment over stage or geography[3]. The firm invests across all stages and maintains offices in both New York and Minneapolis, with willingness to invest nationally[3]. This flexibility allows the firm to back founders solving specific regional healthcare challenges—whether school-based mental health, care for frail seniors, or rural healthcare access—rather than forcing all investments into a standardized mold.
The firm's limited partners and advisors include many of the largest national payers, health systems, and successful healthcare leaders[3]. This creates a virtuous cycle: LPs gain insight into emerging healthcare innovation, while portfolio companies gain direct access to potential customers and strategic partners.
Town Hall Ventures operates at the intersection of two powerful trends reshaping American healthcare: the shift toward value-based care models and the growing recognition that healthcare inequity represents both a moral imperative and a massive market opportunity[3][5].
The firm's timing proved prescient. As healthcare systems increasingly face pressure to improve outcomes while reducing costs, and as policymakers prioritize health equity, the market for solutions addressing underserved populations has expanded dramatically. Town Hall's portfolio companies—operating in areas like behavioral health, primary care, social determinants of health, and value-based payment models—directly address these systemic pressures[1].
Beyond individual portfolio company success, Town Hall influences the broader healthcare venture ecosystem by demonstrating that impact and returns are not mutually exclusive. The firm's unicorn-level exits validate the thesis that solving healthcare problems for underserved populations can generate exceptional financial outcomes. This shifts capital allocation patterns across the venture industry, encouraging other firms to take healthcare equity seriously as an investment thesis rather than merely a corporate social responsibility initiative.
Town Hall Ventures has established itself as the premier venture platform for healthcare founders committed to serving underserved populations. The firm's combination of policy expertise, operational support, and ecosystem access creates a defensible competitive position in healthcare venture investing.
Looking forward, Town Hall will likely expand its influence as healthcare policy continues evolving toward value-based care and equity-focused metrics. The firm's ability to help portfolio companies navigate regulatory changes and build relationships with payers positions it well to capitalize on this shift. Additionally, as healthcare technology increasingly intersects with social determinants of health—housing, food security, transportation—Town Hall's focus on these areas should drive continued deal flow and portfolio company success.
The firm's trajectory suggests that the future of healthcare venture capital belongs to investors who combine financial acumen with genuine healthcare system expertise and authentic commitment to underserved populations. Town Hall Ventures has already proven this model works; the question is whether the firm can scale its impact while maintaining the operational rigor and mission alignment that define its approach.
Key people at Town Hall Ventures.
